Chelsea Therapeutics Announces Exercise of Over-Allotment Option and …

Exercise of the over-allotment option increases the net proceeds to the company, after underwriting discounts and commissions and estimated offering expenses, from approximately $19.2 million to $22.1 million. Chelsea intends to use the net proceeds …
See all stories on this topic »